HuGE Literature Finder
Records
1
-
5
| Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology, research and practice 2020 Sep 216 (9): 153116. Pu Xiaohong, Zhu Liya, Li Feng, Zheng Jinyu, Wu Hongyan, Fu Yao, Chen Jun, Qi Lia |
| Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis. Przegla?d gastroenterologiczny 2015 10 (2): 108-17. Li Junshan, Han Tianjie, Xu Linlin, Luan Xiaoti |
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
| Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Human pathology 2013 Feb . Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR |
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 Jan . Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: